ANDREW HARRIS: Open Payments
NPI 1548931116 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 5 payments from 5 companies in 2025. Trend: 2023 $242 · 2024 $432 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $137 |
| Vanda Pharmaceuticals Inc. | 1 | $108 |
| E.R. Squibb & Sons, L.L.C. | 1 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Tris Pharma Inc | 1 | $17 |
Products named: INGREZZA, FANAPT, COBENFY, CAPLYTA, Dyanavel XR.
Industry payments across NC — which companies pay providers there.
